The North America and Latin America Infusion Pump Market was valued at USD 2,140 Million in 2025 and is projected to reach USD 4,920 Million by 2035, expanding at a CAGR of 7.9% from 2024 to 2035. Rising prevalence of chronic diseases, increased adoption of advanced healthcare technologies, and supportive government initiatives are significant factors propelling market growth across these regions. Major players such as Baxter International, B. Braun Melsungen AG, and Smiths Medical are investing in technological advancements to strengthen their market positioning.
The economic impact of tariffs on "North America Latin America Infusion Pump Market".
Market Growth Drivers
Increased Incidence of Chronic Diseases: The rising occurrence of diseases such as diabetes, cancer, and cardiovascular disorders has significantly boosted demand for infusion pump therapies in North and Latin America. Infusion pumps are essential for precise drug delivery in long-term care, creating continual demand in both hospital and home-care settings. Companies like Baxter International are expanding their infusion pump portfolios to cater to growing therapeutic needs, while also investing in patient-centric solutions for chronic disease management.
Technological Advancements and Integration of IoT: Technological innovation has led to the development of smarter, more reliable infusion pumps integrated with software upgrades, wireless connectivity, and remote monitoring features. B. Braun Melsungen AG, for example, has launched connected pumps that enhance patient safety through real-time alarms and dose-error reduction. These advancements streamline healthcare workflows and minimize medication errors, thus driving market growth.
Market Trends
Shift Towards Ambulatory & Homecare Settings: As healthcare systems aim to reduce hospital admissions and healthcare costs, there is a substantial shift towards ambulatory and homecare infusion therapies. Smiths Medical has launched compact portable infusion systems that cater to patients requiring long-term medication outside hospital settings. This trend enables continuous treatment for patients with chronic illnesses, making it a critical driver for market demand.
Focus on Smart Infusion Pump Systems: There is an increasing demand for smart infusion pump systems equipped with real-time monitoring, analytics, and connectivity features. Companies such as ICU Medical are investing in cloud-enabled pumps with workflow automation and integration capabilities with hospital EMR systems. This enhances user compliance, improves patient safety, and enables predictive maintenance, positioning smart pumps as a standard in modern healthcare facilities.
Market Opportunities
Latin America's Untapped Healthcare Infrastructure: Rapid investments in healthcare infrastructure across Latin America present significant growth opportunities for infusion pump manufacturers. Medtronic has recently announced partnerships with local healthcare institutions to establish advanced infusion therapy centers, tapping into underpenetrated markets in Brazil and Mexico.
Rising Adoption of Personalized Medicine: Increasing focus on precision and personalized medicine is boosting demand for user-friendly, programmable infusion pumps. Opportunities exist for companies that can deliver customizable solutions, such as Fresenius Kabi's recently introduced modular infusion pumps tailored to specific patient requirements.
North America Latin America Infusion Pump Market Revenue (USD Million), 2020-2035
The market is forecasted to grow steadily from USD 1,250 Million in 2020 to USD 4,920 Million by 2035. This chart demonstrates strong year-on-year growth, with key inflection points around 2025 as advanced technologies and increased investments drive adoption in both hospital and home-care segments. The steep upward trajectory post-2025 highlights the impact of telemedicine integration and increased healthcare spending. Major breakthroughs in infusion technology, patient monitoring, and government support further accelerate revenue expansion, reinforcing the region’s leadership in infusion therapies.
North America Latin America Infusion Pump Market by Region Share (%), 2025
In 2025, the market is majorly concentrated in North America, capturing approximately 67% of the total revenue due to its advanced healthcare infrastructure and early technology adoption. The U.S. dominates regional growth, followed by Canada and Mexico. Latin America, including Brazil and Argentina, is rapidly emerging with 23% share, spurred by government health initiatives and public-private partnerships. Other regions collectively account for the remaining 10%. The pie chart reflects the regional disparities, with significant room for growth in Latin America, enabled by infrastructural expansion and strategic collaborations.
Recent Developments
In March 2024, Baxter International announced the launch of its next-generation spectrum IQ Infusion Pump in key North American hospitals. The system features enhanced drug library capabilities and advanced wireless integration, improving infusion accuracy and patient safety. Early pilot studies with major hospital partners have demonstrated significant reductions in medication errors, reinforcing Baxter’s commitment to innovation.
In April 2024, B. Braun Melsungen AG expanded its partnership with hospital networks in Mexico and Brazil to deliver smart infusion systems across both public and private clinics. The move is part of a region-wide initiative to modernize infusion therapy, providing localized training and technical support. The collaboration accelerates the penetration of intelligent infusion technologies in rapidly developing healthcare markets.
In May 2024, Smiths Medical unveiled a portable, battery-powered infusion pump targeting ambulatory and home-care patients in the U.S. and Canada. Addressing the demand for remote patient management, the new device integrates with digital health platforms, supporting real-time monitoring and care continuity. Early adoption in home-health networks indicates strong market acceptance and growth potential for mobile infusion solutions.